In the last trading session, 1.41 million shares of the Sana Biotechnology Inc (NASDAQ:SANA) were traded, and its beta was 1.75. Most recently the company’s share price was $1.87, and it changed around -$0.02 or -1.06% from the last close, which brings the market valuation of the company to $421.64M. SANA currently trades at a discount to its 52-week high of $10.50, offering almost -461.5% off that amount. The share price’s 52-week low was $1.26, which indicates that the current value has risen by an impressive 32.62% since then.
Sana Biotechnology Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.29. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 1 recommended SANA as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Sana Biotechnology Inc is expected to report earnings per share of -0.2 for the current quarter.
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Instantly SANA has showed a red trend with a performance of -1.06% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.0350 on recent trading dayincreased the stock’s daily price by 8.11%. The company’s shares are currently up 14.72% year-to-date, but still up 6.25% over the last five days. On the other hand, Sana Biotechnology Inc (NASDAQ:SANA) is 36.50% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $8, which translates to bulls needing to increase their stock price by 76.62% from its current value. Analyst projections state that SANA is forecast to be at a low of $8 and a high of $8.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -10.60%. Sana Biotechnology Inc earnings are expected to increase by 25.01% in 2025, but the outlook is positive 11.81% per year for the next five years.
SANA Dividends
Sana Biotechnology Inc’s next quarterly earnings report is expected to be released in June.
FLAGSHIP PIONEERING INC., with 10.6645% or 25.0 million shares worth $136.51 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and SMALLCAP WORLD FUND INC were the top two Mutual Funds as of Mar 31, 2025 . The former held 9.68 shares worth $18.1 million, making up 4.29% of all outstanding shares. On the other hand, SMALLCAP WORLD FUND INC held roughly 5.45 shares worth around $10.19 million, which represents about 2.42% of the total shares outstanding.
